--- title: "Attovia Therapeutics (ATTO) news: IPO and offering" url: "https://aibio.space/companies/attovia-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ATTO IPO and offering news: Attovia Therapeutics prices IPO of 17,000,000 shares at $17.00. Attovia Therapeutics, Inc. (NASDAQ: ATTO), United States." --- ATTO Attovia Therapeutics, Inc. NASDAQ · United States # Attovia Therapeutics (ATTO) news ATTO IPO and offering news Financings · 2026-08-05 ## [Attovia Therapeutics prices IPO of 17,000,000 shares at $17.00](https://aibio.space/news/attovia-therapeutics-prices-ipo-17-000-000-shares-17-00/) The offering totals $289,000,000 before fees. The shares have been approved for listing on the Nasdaq Global Market as ATTO. ## Latest Attovia Therapeutics news 1. 2026-07-14 Financings [Attovia Therapeutics files for IPO, plans Nasdaq listing as ATTO](https://aibio.space/news/attovia-therapeutics-files-ipo-plans-nasdaq-listing-atto/) Attovia Therapeutics, Inc. filed a Form S-1 on July 14, 2026. The cover leaves the share count and price range blank. ## Attovia Therapeutics at a glance - **Ticker**: ATTO - **Listing**: NASDAQ - **Country**: United States ### Related companies - [Carisma Therapeutics](https://aibio.space/companies/carisma-therapeutics/) OTC: CARM - [Kura Oncology](https://aibio.space/companies/kura-oncology/) NASDAQ: KURA - [Disc Medicine](https://aibio.space/companies/disc-medicine/) NASDAQ: IRON - [Altimmune](https://aibio.space/companies/altimmune/) NASDAQ: ALT - [Alector](https://aibio.space/companies/alector/) NASDAQ: ALEC - [Odyssey Therapeutics](https://aibio.space/companies/odyssey-therapeutics/) NASDAQ: ODTX - [Xeris Biopharma Holdings](https://aibio.space/companies/xeris-biopharma/) NASDAQ: XERS - [Cel-Sci](https://aibio.space/companies/cel-sci/) AMEX: CVM ### Also on NASDAQ - [Insmed](https://aibio.space/companies/insmed/) INSM - [Vivani Medical](https://aibio.space/companies/vivani-medical/) VANI - [Traws Pharma](https://aibio.space/companies/traws-pharma/) TRAW - [TransCode Therapeutics](https://aibio.space/companies/transcode-therapeutics/) RNAZ - [Viridian Therapeutics](https://aibio.space/companies/viridian-therapeutics/) VRDN - [Advanced Biomed](https://aibio.space/companies/advanced-biomed/) ADVB ## Questions about Attovia Therapeutics When did Attovia Therapeutics go public? Our latest story on this, dated Aug 5, 2026: "Attovia Therapeutics prices IPO of 17,000,000 shares at $17.00". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/attovia-therapeutics-prices-ipo-17-000-000-shares-17-00/). Has Attovia Therapeutics raised money recently? Our latest story on this, dated Aug 5, 2026: "Attovia Therapeutics prices IPO of 17,000,000 shares at $17.00". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/attovia-therapeutics-prices-ipo-17-000-000-shares-17-00/). What is the ticker symbol of Attovia Therapeutics? Attovia Therapeutics, Inc. trades under the ticker ATTO on NASDAQ. Where is Attovia Therapeutics listed? Attovia Therapeutics, Inc. is listed on NASDAQ. What is the SEC CIK of Attovia Therapeutics? The SEC Central Index Key (CIK) for Attovia Therapeutics, Inc. is 2058707. Its filings are on SEC EDGAR. How many shares does Attovia Therapeutics have outstanding? 45,651,262 shares as of 2026-08-31, per the cover page of its 10-Q filed 2026-09-02. Which country or territory is Attovia Therapeutics listed under? Our directory records Attovia Therapeutics, Inc. under United States. What does Attovia Therapeutics do? Our directory classifies Attovia Therapeutics, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Attovia Therapeutics? The ISIN recorded for Attovia Therapeutics, Inc. is US04987L1026. Does aibio.space cover Attovia Therapeutics? aibio.space lists Attovia Therapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Attovia Therapeutics incorporated? SEC records list its state or country of incorporation as DE. What is the latest Attovia Therapeutics (ATTO) stock news? Our latest story on Attovia Therapeutics, dated Aug 5, 2026: "Attovia Therapeutics prices IPO of 17,000,000 shares at $17.00". The offering totals $289,000,000 before fees. The shares have been approved for listing on the Nasdaq Global Market as ATTO. [Source](https://aibio.space/news/attovia-therapeutics-prices-ipo-17-000-000-shares-17-00/). How much cash does Attovia Therapeutics have? From our story of Aug 5, 2026: The prospectus gives a preliminary figure of approximately $115.1 million in cash, cash equivalents and marketable securities as of June 30, 2026. [Source](https://aibio.space/news/attovia-therapeutics-prices-ipo-17-000-000-shares-17-00/). Is Attovia Therapeutics a smaller reporting company? SEC records list Attovia Therapeutics, Inc.'s filer category as: Non-accelerated filer
Smaller reporting company
Emerging growth company. Where is Attovia Therapeutics headquartered? SEC records list its business address as 1091 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070. ## Investor discussion: Attovia Therapeutics Members talk about Attovia Therapeutics (ATTO). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Attovia Therapeutics, newest first. Each line links the filing it comes from. 1. 2026-08-05 Financings Filed a final prospectus for a securities offering. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/2058707/000119312526334997/d40469d424b4.htm) 2. 2026-07-14 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/2058707/000119312526303256/d40469ds1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ATTO on TradingView](https://www.tradingview.com/symbols/NASDAQ-ATTO/). ## SEC filings and registration - **SEC name**: Attovia Therapeutics, Inc. - **CIK**: 2058707 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: ATTO (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company
Emerging growth company - **Business address**: 1091 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070 - **Phone**: 5103995001 - **Shares outstanding**: 45,651,262 as of 2026-08-31 (10-Q filed 2026-09-02) ### Recent filings (8-K and 6-K are the company's own announcements) - [10-Q](https://www.sec.gov/Archives/edgar/data/2058707/000119312526380228/atto-20260630.htm) filed 2026-09-02 - [8-K](https://www.sec.gov/Archives/edgar/data/2058707/000119312526380215/atto-20260902.htm) filed 2026-09-02 - [8-K](https://www.sec.gov/Archives/edgar/data/2058707/000119312526338037/d155197d8k.htm) filed 2026-08-06 - [S-1](https://www.sec.gov/Archives/edgar/data/2058707/000119312526303256/d40469ds1.htm) filed 2026-07-14 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002058707), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Attovia Therapeutics, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ATTO, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Attovia Therapeutics, Inc. - **Ticker**: ATTO - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: US04987L1026 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-ATTO/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/attovia-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Attovia Therapeutics (ATTO) news: IPO and offering", 2026-10-31, https://aibio.space/companies/attovia-therapeutics/